DNA damage drives antigen diversification in Trypanosoma brucei
Article Date: 08 April 2026
Article URL: https://www.nature.com/articles/s41586-026-10337-6
Article Image: https://www.nature.com/articles/s41586-026-10337-6/figures/1
Summary
This Nature study shows that DNA double-strand breaks within the actively expressed variant surface glycoprotein (VSG) gene in Trypanosoma brucei trigger the formation of mosaic VSGs by templated gene conversion. The authors developed a high-confidence targeted sequencing method (VSG-AMP-seq) to detect thousands of rare recombination events and used CRISPR–Cas9 to introduce controlled breaks in vitro. Mosaic formation is driven by short regions of sequence homology, can use donor templates located anywhere in the genome, requires RAD51 and BRCA2, and produces small insertions that substantially reduce antibody binding. The in vitro mosaics mirror many events observed in infected mice, and mosaics are particularly enriched in extravascular tissue reservoirs where parasites persist.
Key Points
- Targeted Cas9-induced double-strand breaks within an active VSG coding sequence reproducibly generate mosaic VSGs identical to those seen in vivo.
- VSG-AMP-seq, a barcoded anchored multiplex PCR sequencing method, enables sensitive detection and high-confidence consensus calling of thousands of rare recombination events.
- Mosaic recombination is driven by sequence homology: short perfect matches (median ~6–12 bp) flank templated insertions, and ~100 bp of imperfect homology is sufficient for efficient usage of a donor.
- Donor templates can be used regardless of genomic location (minichromosomes, rDNA spacer, tubulin array) — genomic context is not a strict barrier.
- Formation of mosaics is a templated gene conversion event (donor remains intact) and depends on homologous-recombination factors RAD51 and BRCA2; RAD51 loss abolishes mosaics in vitro.
- Most VSGs (≳75%) are in families and therefore capable of diversification by break-induced mosaic formation.
- Small mosaic insertions at the apex/top of the VSG N-terminal lobe markedly reduce polyclonal antibody binding (often 50–75% drop), showing that modest sequence changes can provide immune evasion.
- Mosaic VSGs accumulate in extravascular tissue niches during infection, suggesting tissues act as sites for iterative diversification under reduced clearance pressure.
Content summary
The authors engineered tetracycline-inducible Cas9 systems in EATRO1125 and Lister427 T. brucei strains and introduced site-specific breaks across the AnTat1.1 VSG (and other VSGs). They developed VSG-AMP-seq, which uses long unique molecular identifiers to collapse reads into high-confidence consensus sequences and thereby avoid PCR chimera artefacts. Cas9 cuts positioned within the VSG coding sequence produced thousands of distinct mosaic recombinants clustered around the break site. Most recombination events comprised short insertions (mean ~45–55 bp) made at regions of shared sequence, with donor choice biased to closely related family members when those exist.
By swapping VSG donors between strains and inserting truncated donors at ectopic loci, the team showed that mosaics are templated gene conversion events that can draw donors from anywhere in the genome and that as little as ~100 bp (and in some cases ~200 bp) of flanking homology suffices for efficient recombination. Knockouts revealed that BRCA2 reduction lowered mosaic formation and RAD51 loss abolished it in vitro, implicating canonical homologous recombination machinery. In infections of B-cell-deficient (µMT) and wild-type mice, mosaic patterns resembled in vitro findings but with broader event distribution in vivo; tissue reservoirs showed higher mosaic abundance, supporting a role for tissue niches in iterative diversification. Structural modelling and flow cytometry established that even tiny N-terminal changes can substantially decrease antibody binding, offering a mechanistic route to immune escape.
Context and relevance
This paper clarifies a core mechanism by which T. brucei expands its antigenic repertoire beyond the limited set of intact VSG genes — by using DNA damage and flexible, homology-driven gene conversion to stitch together new VSGs from fragments and pseudogenes. The findings show how the parasite repurposes ancient, degenerate sequences via an error-tolerant RAD51/BRCA2-mediated pathway, favouring outcomes that selectively alter exposed, antibody-targeted regions of the VSG. That has broad implications: similar templated recombination may underlie antigen diversification in other pathogens (for example, Plasmodium and Giardia) and could influence how we think about immune evasion, tissue reservoirs, and potential interventions that target DNA-repair pathways.
Author note (punchy)
Punchy summary: the parasite uses DNA damage as a creative hack — break a VSG, and the repair machinery cobbles together tiny bits from distant, often-decayed genes to make a new surface coat that dodges antibodies. This is not sloppy noise: it’s a targeted, RAD51-dependent process that preferentially alters the part of the protein the host targets. If you work on antigenic variation, DNA repair or immune evasion, read this closely — it changes how we think about antigen generation and where to intercept it.
Why should I read this?
Because it explains, in plain experimental terms, how trypanosomes invent new surface proteins from broken bits of old ones. It’s clever, repeatable and gives you a toolkit (VSG-AMP-seq plus Cas9 breaks) to study antigen diversification. If you want to understand chronic infection, immune escape or how genome repair can fuel pathogen evolution, this saves you the slog of hunting through scattered papers — the authors did the heavy lifting and laid out the mechanism.